Evidence map›Paper›PMID 29923116›Full record

ArticlePflugers Archiv : European journal of physiology2018

Cardiospecific deletion of αE-catenin leads to heart failure and lethality in mice.

Volodymyr V Balatskyi, Larysa L Macewicz, Ana-Maria Gan, Sergii V Goncharov, Paulina Pawelec, Georgiy V Portnichenko, Tetiana Yu Lapikova-Bryginska, Viktor O Navrulin, Victor E Dosenko, Adam Olichwier and 2 more

Erratum issuedAbstract read
PubMed Publisher
In one paragraph

Article in Pflugers Archiv : European journal of physiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Volodymyr V BalatskyiDepartment of Human Genetics, Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, 150 Akad. Zabolotnogo str, Kyiv, 03680, Ukraine.
Larysa L MacewiczDepartment of Human Genetics, Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, 150 Akad. Zabolotnogo str, Kyiv, 03680, Ukraine.
Ana-Maria GanLaboratory of Molecular Medical Biochemistry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur str, 02-093, Warsaw, Poland.
Sergii V GoncharovDepartment of General and Molecular Pathophysiology, Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, 4 Bogomoletz str, Kyiv, 01024, Ukraine.
Paulina PawelecLaboratory of Cell Signaling and Metabolic Disorders, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur str, 02-093, Warsaw, Poland.
Georgiy V PortnichenkoDepartment of General and Molecular Pathophysiology, Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, 4 Bogomoletz str, Kyiv, 01024, Ukraine.
Tetiana Yu Lapikova-BryginskaDepartment of General and Molecular Pathophysiology, Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, 4 Bogomoletz str, Kyiv, 01024, Ukraine.
Viktor O NavrulinLaboratory of Molecular Medical Biochemistry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur str, 02-093, Warsaw, Poland.
Victor E DosenkoDepartment of General and Molecular Pathophysiology, Bogomoletz Institute of Physiology, National Academy of Sciences of Ukraine, 4 Bogomoletz str, Kyiv, 01024, Ukraine.
Adam OlichwierLaboratory of Molecular Medical Biochemistry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur str, 02-093, Warsaw, Poland.
Pawel DobrzynLaboratory of Molecular Medical Biochemistry, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 3 Pasteur str, 02-093, Warsaw, Poland.
Oksana O PivenDepartment of Human Genetics, Institute of Molecular Biology and Genetics, National Academy of Sciences of Ukraine, 150 Akad. Zabolotnogo str, Kyiv, 03680, Ukraine. o.o.piven@imbg.org.ua.
National Academy of Sciences of Ukraine · UAPolish Academy of Sciences · PLInstitute of Molecular Biology and Genetics · UAInstytut Biologii Doświadczalnej im. Marcelego Nenckiego · PLBogomoletz Institute of Physiology · UA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

αE-catenin is a component of adherens junctions that link the cadherin-catenin complex to the actin cytoskeleton. The signaling function of this protein was recently revealed. In the present study, we investigated the role of αE-catenin in the pathogenesis of heart failure. We mated αE-catenin conditional knockout mice with αMHC-Cre mice and evaluated their mutant offspring. We found that αE-catenin knockout caused enlargement of the heart and atria, fibrosis, the upregulation of hypertrophic genes, and the dysregulation of fatty acid metabolism via the transcriptional activity of Yap and β-catenin. The activation of canonical Wnt and Yap decreased the activity of main regulators of energy metabolism (i.e., adenosine monophosphate-activated protein kinase and peroxisome proliferator-activated receptor α) and dysregulated hypertrophic pathway activity (i.e., phosphatidylinositide 3-kinase/Akt, cyclic adenosine monophosphate/protein kinase A, and MEK1/extracellular signal regulated kinase 1/2). The loss of αE-catenin also negatively affected cardio-hemodynamic function via the protein kinase A pathway. Overall, we found that the embryonic heart-specific ablation of αE-catenin leads to the development of heart failure with age and premature death in mice. Thus, αE-catenin appears to have a crucial signaling function in the postnatal heart, and the dysfunction of this gene causes heart failure through canonical Wnt and Yap activation.

Indexed as

Gene DeletionAdaptor Proteins, Signal Transducingalpha CateninAnimalsbeta CateninCell Cycle ProteinsEnergy MetabolismHeart FailureHemodynamicsLipid MetabolismMiceMyocardiumPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPhosphoproteinsWnt Signaling PathwayYAP-Signaling ProteinsAdaptor Proteins, Signal Transducingalpha Cateninbeta CateninCell Cycle ProteinsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaPhosphoproteinsPpargc1a protein, mouseYap1 protein, mouseYAP-Signaling ProteinsHeart failureHeart metabolismHIPPO signalingWnt signalingαE-catenin

Identifiers

PMID29923116
OpenAlexW2808764469

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.